202318cites
Bestatin analogs-4-quinolinone hybrids as antileishmanial hits: Design, repurposing rational, synthesis, in vitro and in silico studiesEuropean Journal of Medicinal Chemistry, Research on Leishmaniasis Studies
UniversitiesWaleed A. Bayoumi
Active, last published 2026
Waleed A.
Bayoumi
“Research profile drawn from open scholarly records.”
Mansoura University
Claim Your Profile0
H-index
0
Citations
Waleed has not officially claimed their profile. If you are Waleed, claim it free.
Claim Your Profile01 · About the work
What I study
research summary for Waleed A. Bayoumi will appear here once their profile is updated.
02 · Reach
Publication output and reach
Waleed's work has been cited 0 times across 3 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
06 · Where I am
Affiliations
CurrentlyMansoura University
Research themes (UN SDGs)
07 · Selected work
Recent publications
2023Open access18cites
Developing multitarget coumarin based anti-breast cancer agents: synthesis and molecular modeling studyScientific Reports, Synthesis and biological activity
20238cites
Targeting carbonic anhydrases II/IX/XII with novel series of coumarin-based compounds: Synthesis, biological activity and molecular dynamics analysisJournal of Molecular Structure, Enzyme function and inhibition
2024Open access1cites
Novel Quinoline-3,4-dihydropyrimidinone Hybrids Privileged Scaffolds: Design, Synthesis, and Cytotoxic EvaluationDelta University Scientific Journal, Multicomponent Synthesis of Heterocycles
202436cites
Novel quinazolin-2-yl 1,2,3-triazole hybrids as promising multi-target anticancer agents: Design, synthesis, and molecular docking studyBioorganic Chemistry, Cancer therapeutics and mechanisms
Are you Waleed?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
No commitment required